Iterum Therapeutics plc (ITRM)
ITRM Stock Price Chart
Explore Iterum Therapeutics plc interactive price chart. Choose custom timeframes to analyze ITRM price movements and trends.
ITRM Company Profile
Discover essential business fundamentals and corporate details for Iterum Therapeutics plc (ITRM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
25 May 2018
Employees
9.00
Website
https://www.iterumtx.comCEO
Corey N. Fishman
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
ITRM Financial Timeline
Browse a chronological timeline of Iterum Therapeutics plc corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 5 Feb 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.13.
Earnings released on 5 Aug 2025
EPS came in at -$0.16 falling short of the estimated -$0.13 by -23.08%.
Earnings released on 13 May 2025
EPS came in at -$0.14 matching the estimated -$0.14.
Earnings released on 7 Feb 2025
EPS came in at -$0.12 surpassing the estimated -$0.24 by +50.00%.
Earnings released on 14 Nov 2024
EPS came in at -$0.30 falling short of the estimated -$0.23 by -30.43%.
Earnings released on 14 Aug 2024
EPS came in at -$0.30 surpassing the estimated -$0.52 by +42.31%.
Earnings released on 13 May 2024
EPS came in at -$0.46 surpassing the estimated -$0.57 by +19.30%.
Earnings released on 28 Mar 2024
EPS came in at -$0.94 surpassing the estimated -$1.02 by +7.84%, while revenue for the quarter reached $2.62M .
Earnings released on 14 Nov 2023
EPS came in at -$0.30 surpassing the estimated -$0.91 by +67.03%.
Earnings released on 11 Aug 2023
EPS came in at -$0.95 falling short of the estimated -$0.80 by -18.75%.
Earnings released on 12 May 2023
EPS came in at -$0.78 surpassing the estimated -$0.80 by +2.50%.
Earnings released on 16 Mar 2023
EPS came in at -$0.41 surpassing the estimated -$1.22 by +66.39%.
Earnings released on 10 Nov 2022
EPS came in at -$2.38 falling short of the estimated -$1.00 by -138.00%.
Stock split effective on 18 Aug 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 12 Aug 2022
EPS came in at -$0.60 surpassing the estimated -$1.05 by +42.86%.
Earnings released on 13 May 2022
EPS came in at -$0.30 surpassing the estimated -$0.75 by +60.00%.
Earnings released on 28 Mar 2022
EPS came in at -$0.30 surpassing the estimated -$0.60 by +50.00%.
Earnings released on 12 Nov 2021
EPS came in at $0.30 falling short of the estimated $1.80 by -83.33%.
Earnings released on 13 Aug 2021
EPS came in at $0.60 surpassing the estimated -$0.97 by +161.86%.
Earnings released on 14 May 2021
EPS came in at -$12.14 falling short of the estimated -$0.90 by -1.25K%.
Earnings released on 12 Mar 2021
EPS came in at -$4.20 falling short of the estimated -$3.00 by -40.00%.
Earnings released on 16 Nov 2020
EPS came in at -$5.10 surpassing the estimated -$6.45 by +20.93%.
ITRM Stock Performance
Access detailed ITRM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.